Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

Patent 10251892 was granted and assigned to Incyte on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Liangxing Wu0

Wenqing Yao0

Alexander Sokolsky0

Date of Patent

April 9, 2019

0

Patent Application Number

156276650

Date Filed

June 20, 2017

0

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

0

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same

...

Patent Primary Examiner

Jeffrey H Murray

0

Patent abstract

The present disclosure relates to bicyclic heterocycles of Formula (I′), and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 and/or FGFR4 enzyme and are useful in the treatment of FGFR-associated diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool